Fire & Flower To Close Three Alberta Stores; Q4 Loss Widens

Canadian cannabis company Fire and Flower Holdings Corp. said Thursday that it will close three locations in Alberta under a restructuring plan, enabling it to deploy resources and allocate capital to locations with higher profit potential. The company also reported a net loss for the fourth quarter that widened from last year.

from RTT - Earnings https://ift.tt/3bWGDBU
via IFTTT

Shot Roster: COVID-19 Vaccines In Human Trials

The ongoing COVID-19 pandemic has sickened over 3.25 million people and has killed 233,014 people, according to data from Johns Hopkins University.

from RTT - Biotech https://ift.tt/2W9swCs
via IFTTT

Kellogg Company Affirms Full-year Financial Guidance - Quick Facts

Kellogg Company (K) affirmed its full-year financial guidance, with sales and profit delivery shifting toward the first half of the year. Adjusted earnings per share, on a currency-neutral basis, is projected to decline in a range of 3% to 4%. Adjusted operating profit on a currency-neutral basis is anticipated to decline approximately 4%, for the fiscal year. The company continues to target organic net sales growth in a range of 1% to 2%.

from RTT - Earnings https://ift.tt/3f1F9s1
via IFTTT

Element Solutions President And COO Scot Benson To Retire - Quick Facts

While reporting its financial results for the first quarter on Thursday, Element Solutions Inc. (ESI) announced the upcoming retirement of Scot Benson from his current role as President and Chief Operating Officer of the company, effective June 15, 2020. Benson will continue to serve as a member of the Board.

from RTT - Earnings https://ift.tt/35je0Mq
via IFTTT

Altria Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Thursday, Altria Group, Inc. (MO) said it is withdrawing its adjusted earnings guidance for the full-year 2020 and its 2020 - 2022 adjusted earnings growth objective, due to the uncertain COVID-19 impacts on its diverse business model.

from RTT - Earnings https://ift.tt/3bU4CkU
via IFTTT

FDA Gives Nod To Medtronic's Hemodialysis Device For Pediatric Patients

The U.S. Food and Drug Administration granted marketing authorization to Medtronic Inc.'s CARPEDIEM System, a new device for continuous dialysis therapy for use in pediatric patients with certain kidney conditions. The system is indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms.

from RTT - Biotech https://ift.tt/2So9VkS
via IFTTT

Intercontinental Exchange Sees Q2 Data Revenues Of $565 Mln To $570 Mln

While reporting its financial results for the first quarter on Thursday, Intercontinental Exchange, Inc. (ICE) said it expects data revenues for the second quarter of 2020 in a range of $565 million to $570 million.

from RTT - Earnings https://ift.tt/2SjWe6s
via IFTTT

Baxter Says Unable To Provide Q2, FY20 Outlook Due To COVID-19 - Quick Facts

While reporting its first-quarter financial results on Thursday, Baxter International Inc. (BAX) said it is not in a position to provide guidance for the second quarter or full-year 2020 at this time due to the uncertainty around the potential financial impacts from the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3bREHKS
via IFTTT

Goodyear Tire Plans Phased Production Restart In Q2; To Cut Payroll Costs

While reporting its first-quarter financial results on Thursday, Goodyear Tire & Rubber Co. (GT) said it is planning a phased restart of production during the second quarter, which began earlier this month with some of its commercial truck tire facilities in the U.S. and Europe. The company expects the majority of its manufacturing facilities to resume operations by the end of May.

from RTT - Earnings https://ift.tt/3eZBLxL
via IFTTT

McDonald's Q1 Profit Down, Misses View

McDonald's Corp. (MCD) reported a profit for the first-quarter that declined 17 percent from last year, reflecting weak sales performance due to restaurant closures, limited operations and dramatic changes in consumer behavior as a result of COVID-19. Global comparable sales declined 3.4%.

from RTT - Earnings https://ift.tt/3c2Q4jj
via IFTTT

Comcast Warns COVID-19 To Have Adverse Impact On Near-to-medium Term Results

While reporting its first-quarter financial results on Thursday, Comcast Corp. (CMCSA, CMCSK) said that while its Cable Communications results were strong in the first quarter of 2020, it will be negatively affected in the second quarter by the significant deterioration in domestic economic conditions and by the costs associated with the company's support of customer connectivity as the population increasingly works and learns remotely from home.

from RTT - Earnings https://ift.tt/2yUrySz
via IFTTT

ConocoPhillips Reports Q1 Production Results; Announces Additional Curtailments

ConocoPhillips (COP) reported first quarter production excluding Libya of 1,278 thousand barrels of oil equivalent per day (MBOED), a decrease of 40 MBOED from the same period a year ago. Adjusting for closed and pending dispositions, production

from RTT - Earnings https://ift.tt/2VPwvoL
via IFTTT

Twitter Q1 Monetizable Daily Active Usage Up 24% YoY - Quick Facts

Twitter, Inc. (TWTR) reported first quarter average monetizable daily active users (mDAU) of 166 million, compared to 134 million, prior year. Average international mDAU was 133 million, compared to 105 million. Average US mDAU were 33 million, compared to 28 million, last year.

from RTT - Earnings https://ift.tt/35hHJFL
via IFTTT

Nielsen Holdings Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Thursday, Nielsen Holdings plc (NLSN) slashed its adjusted earnings and revenue growth guidance for the full-year 2020, to reflect its most recent expectations, incorporating the estimated impact of COVID-19.

from RTT - Earnings https://ift.tt/3aOYnh1
via IFTTT

Willis Towers Watson Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, Willis Towers Watson (WLTW) said it is withdrawing and consequently fully disclaims its full-year 2020 guidance, due to the uncertainties caused by the coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/2SlLCEk
via IFTTT

Cigna Maintains FY20 Outlook - Quick Facts

While reporting financial results for the first quarter on Thursday, health service company Cigna Corp. (CI) maintained its adjusted income from operations and adjusted revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2W9AQlC
via IFTTT

Lancashire Holdings Q1 Gross Premiums Written Up 11.8% - Quick Facts

Lancashire Holdings Limited (LRE.L), a provider of insurance and reinsurance products, Thursday reported 11.8 percent year-over-year growth in its gross premiums written for the first quarter.

from RTT - Earnings https://ift.tt/3f7I7ej
via IFTTT

St. James's Place Q1 Gross Inflows Of Funds Up 12% - Quick Facts

St. James's Place plc (STJ.L), a wealth management group, issued an update on new business inflows and funds under management for the first quarter ended March 31, 2020.

from RTT - Earnings https://ift.tt/2KNx5x6
via IFTTT

Glencore Q1 Own Sourced Copper Production Down 9% - Quick Facts

Glencore Plc (GLCNF.PK, GLNCY.PK, GLEN.L) said Thursday that its own sourced copper production for the first quarter of 2020 declined 9 percent from the year-ago period to 293,300 tonnes. The company noted that no production was reported in the quarter for Mutanda and Mopani.

from RTT - Earnings https://ift.tt/3c25sfP
via IFTTT

Clariant Q1 Continuing Operations EBITDA, Sales Decline - Quick Facts

Specialty chemicals company Clariant AG (CLZNY.PK, CRN.L, CLZNF.PK) on Thursday reported a 14 percent decline in its continuing operations EBITDA for the first quarter to 157 million Swiss francs from a restated 183 million francs in the year-ago period.

from RTT - Earnings https://ift.tt/3fazno3
via IFTTT

Lloyds Banking Q1 Pre-tax Profit Plunges - Quick Facts

Lloyds Banking Group plc (LLOY.L, LYG) reported Thursday that its first-quarter profit before tax plunged 95 percent to 74 million pounds from 1.60 billion pounds in the year-ago period, impacted by a significantly increased impairment charge of 1.43 billion pounds due to the revised economic outlook.

from RTT - Earnings https://ift.tt/2yRRYEG
via IFTTT

Draegerwerk Q1 Net Sales Rise; Order Intake Surges - Quick Facts

German medical and safety technology provider Draegerwerk AG & Co. KGaA (DRWKF.PK) reported Thursday that its first-quarter net sales increased by 6.4 percent in nominal terms to 640.0 million euros from 601.6 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2YpJdMR
via IFTTT

Orange Q1 Revenues Rise; To Propose Dividend Reduction - Quick Facts

French telecommunications operator Orange SA (ORAN) reported Thursday that its first-quarter revenues rose 2.1 percent on a historical basis to 10.39 billion euros from 10.19 billion euros last year. On a comparable basis, revenues increased 1.0 percent.

from RTT - Earnings https://ift.tt/3aVZH1S
via IFTTT

Societe Generale Posts Reported Net Loss In Q1 - Quick Facts

French lender Societe Generale SA (SCGLF.PK, SCGLY.PK) on Thursday reported Group net loss for the first quarter of 326 million euros, compared to net income of 686 million euros in the year-ago period. Loss per share was 0.57 euros, compared to earnings per share of 0.65 euros last year.

from RTT - Earnings https://ift.tt/35hZLaH
via IFTTT

Swiss Re Slips To Loss In Q1 - Quick Facts

Reinsurer Swiss Re (SSREY.PK) on Thursday reported net loss for the first quarter of $225 million, compared to net income of $429 million a year ago. The net loss reflects the impact of COVID-19, notably a pre-tax charge of $476 million for the property and casualty businesses.

from RTT - Earnings https://ift.tt/3d3lFRE
via IFTTT

Celestica Q1 Revenue, Adj. Earnings Beat Estimates - Quick Facts

Celestica Inc. (CLS, CLS.TO) on Wednesday reported IFRS net loss for the first quarter of $3.2 million or $0.02 per share, compared to net income of $90.3 million or $0.66 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2SfIDwX
via IFTTT

Peabody Energy Suspends FY20 Guidance - Quick Facts

While reporting its first-quarter financial results on Wednesday, Peabody Energy Corp. (BTU) said it has decided to suspend its full-year 2020 guidance due to uncertainties with respect to COVID-19.

from RTT - Earnings https://ift.tt/35eMTlT
via IFTTT

Stock Alert: TherapeuticsMD Shares Up 17% On Patent For Contraceptive ANNOVERA

Shares of TherapeuticsMD Inc. (TXMD) are soaring over 17% in pre-market today, after the company announced that the United States Patent and Trademark Office has issued a patent that covers the labeled indication for ANNOVERA, the first and only long-lasting, patient-controlled, procedure-free, reversible prescription contraceptive option for women.

from RTT - Before the Bell https://ift.tt/2W7J1yN
via IFTTT

Stock Alert: Brinker Shares Up 15% In Premarket As Q3 Earnings Beat Estimates

Shares of Brinker International Inc. (EAT) are rising over 15% in pre-market today, after the company reported strong Q3 results.

from RTT - Before the Bell https://ift.tt/3f1z4vo
via IFTTT

Sensient Technologies Reconfirms FY20 Guidance - Quick Facts

While reporting financial results for the first quarter on Wednesday, Sensient Technologies Corp. (SXT), a maker of colors, flavors and fragrances, reconfirmed its guidance for earnings and revenue growth for the full year 2020, based upon current trends.

from RTT - Earnings https://ift.tt/2KN4J5O
via IFTTT

Norfolk Southern Withdraws Outlook For Flat Full-year Revenue - Quick Facts

While reporting its first-quarter financial results on Wednesday, Norfolk Southern Corp. (NSC) said it is withdrawing its previously-issued outlook for flat full-year revenue as well as its outlook for the full-year core operating ratio.

from RTT - Earnings https://ift.tt/2yWBafO
via IFTTT

Belden Slips To Loss In Q1; Increases SG&A Cost Reduction Program To $60 Mln

Belden Inc. (BDC), a supplier of specialty networking solutions, on Wednesday reported attributable net loss for the first quarter of $11.19 million or $0.25 per share, compared to net income of $16.47 million or $0.42 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3aTNJG0
via IFTTT

Boeing Q1 Results Miss Estimates - Quick Facts

Boeing Co. (BA) on Wednesday reported first-quarter net loss attributable to Boeing shareholders of $628 million or $1.11 per share, compared to a profit of $2.15 billion or $3.75 per share in the year-ago quarter, primarily reflecting the impacts of COVID-19 and the 737 MAX grounding.

from RTT - Earnings https://ift.tt/2SiCjVG
via IFTTT

Stock Alert: Chimerix Shares Up 35% In Premarket

Shares of Chimerix Inc. (CMRX) are surging over 35% in pre-market today, after the company announced initiation of a Phase 2/3 study of dociparstat sodium or DSTAT in COVID-19 patients with acute lung injury or ALI.

from RTT - Before the Bell https://ift.tt/2VNxJkh
via IFTTT

American Tower Reduces Mid-point For FY20 Outlook Ranges - Quick Facts

While reporting its financial results for the first quarter on Wednesday, American Tower (AMT) said that aAs of April 29, 2020, it does not anticipate significant impacts to its underlying operating results in 2020 as a result of the coronavirus or COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2y0otR1
via IFTTT

Automatic Data Processing Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the third quarter on Wednesday, technology company Automatic Data Processing Inc. (ADP) slashed its adjusted earnings and revenue growth guidance for the full-year 2020, in light of the expected impact from COVID-19 outbreak.

from RTT - Earnings https://ift.tt/3cZ8aCy
via IFTTT

Tupperware Brands Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Wednesday, Tupperware Brands Corp. (TUP) said it is withdrawing the full year 2020 guidance provided on February 24, 2020, due to the material uncertainty of the duration and extent of the COVID-19 pandemic impact.

from RTT - Earnings https://ift.tt/2YbFQsG
via IFTTT

Volkswagen Q1 Hurt By Covid-19 Impact; Sees Profit In FY20; Stock Up

Shares of Volkswagen Group were gaining around 3 percent in German trading after the automaker said it expects a profit in fiscal 2020, despite being severely hit by Covid-19 pandemic. The company's first-quarter results were substantially lower than the prior year as demand plunged amid the coronavirus-related lockdowns across the world.

from RTT - Earnings https://ift.tt/3aN1DJJ
via IFTTT

Humana Backs FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, health insurer Humana Inc. (HUM) provided earnings and reaffirmed adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/35e8Ilm
via IFTTT

General Electric Q1 Adj. Profit Declines; Industrial Organic Revenues Down 5%

General Electric Company (GE) reported first quarter adjusted GE Industrial earnings per share of $0.06 compared to $0.13, prior year. Adjusted earnings per share was $0.05, a decline of 62% from prior year. On average, 14 analysts polled by Thomson Reuters expected the company to report profit per share of $0.08, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/35fItuP
via IFTTT

Boston Scientific Q1 Adj. EPS Misses View, But Sales Top - Quick Facts

Medical devices company Boston Scientific Corp. (BSX) reported net income for the first quarter of $11 million or $0.01 per share, sharply down from $424 million or $0.30 per share a year ago, and achieved adjusted earnings per share of $0.28 for the period, compared to $0.35 a year ago.

from RTT - Earnings https://ift.tt/2yRmvST
via IFTTT

Enterprise Products Cuts Total 2020 Growth Capital Investments - Quick Facts

While reporting financial results for the first quarter on Tuesday, Enterprise Products Partners L.P. (EPD) said it has reduced its guidance for total 2020 growth capital investments by approximately $1 billion to a range of $2.5 billion to $3.0 billion compared to original guidance. The partnership reduced its guidance for sustaining capital expenditures for 2020 to $300 million from $400 million.

from RTT - Earnings https://ift.tt/3bJf9zo
via IFTTT

Littelfuse Withdraws FY20 Outlook Amid COVID-19; Suspends Share Buyback

While reporting financial results for the first quarter on Wednesday, Littelfuse, Inc. (LFUS) said it is withdrawing its full-year 2020 financial guidance issued on January 29, due to limited visibility of COVID-19 impacts. However, the company provided net sales guidance for the second quarter.

from RTT - Earnings https://ift.tt/2yQRVc4
via IFTTT

Do You Have These Stocks In Your Portfolio? (SNDX, ERYP, IMRA...)

The following are some of the stocks in the healthcare sector that touched a high yesterday. Will the rally continue?

from RTT - Biotech https://ift.tt/2y083YU
via IFTTT

AstraZeneca Q1 Profit Rises; Product Sales Up 15% - Quick Facts

AstraZeneca (AZN.L, AZN) reported that its first quarter profit to owners of the parent increased to $780 million from $593 million, previous year. Reported earnings per share was $0.59, an increase of 27%, or up 33% at CER. Core earnings per share increased by 17%, or up 21% at CER, to $1.05.

from RTT - Earnings https://ift.tt/2ShsIOJ
via IFTTT

Volkswagen Group Q1 Profit Falls; Deliveries Down 23.0% YoY - Quick Facts

The Volkswagen Group (VKW.L, VLKAF.PK, VOW.BE) reported that its first quarter earnings before tax declined to 0.7 billion euros from 4.1 billion euros, previous year. Operating profit before special items decreased significantly by 81.4 percent to 0.9 billion euros.

from RTT - Earnings https://ift.tt/2W7Qii3
via IFTTT

BPMC's VOYAGER Fails, CLSD's NDA Resubmission Faces Delay, SNDX Hits New High

Today's Daily Dose brings you news about Blueprint Medicines' disappointing results from gastrointestinal stromal tumor trial; revised timeline of Clearside Biomedical's resubmission of XIPERE NDA; encouraging trial results of INOVIO's MERS coronavirus vaccine and initial data from Syndax Pharma's acute leukemia trial.

from RTT - Biotech https://ift.tt/2VNKTxP
via IFTTT

Samsung Q1 Profit Down; Warns Of Q2

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) reported a profit for the first-quarter that declined about 4.27 percent from last year. Quarterly operating profit increased 3.43 percent from last year. Sales increased 5.61 percent, due to increasing demand for server and mobile components. The second quarter results are likely to decline as the COVID-19 to impact demand of core products.

from RTT - Earnings https://ift.tt/35goDQs
via IFTTT

Stock Alert: D R Horton Climbs 8% On Upbeat Q2 Results

Shares of D R Horton Inc. (DHI) are rising more than 8 percent or $3.44 in Tuesday's morning trade at $45.56 after the home builder's results for the second quarter beat analysts' estimates. The stock has traded in a range of $25.51 to $62.54 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2ShVJtE
via IFTTT

Stock Alert: Quest Diagnostics Stock Up 7% On Consumer-Initiated Antibody Test Launch

Shares of Quest Diagnostics Inc. (DGX) are rising over 7% in pre-market today, after the company announced the launch of consumer-initiated COVID-19 antibody test through QuestDirect.

from RTT - Before the Bell https://ift.tt/2VHXq5W
via IFTTT

Stock Alert: SmileDirectClub Shares Up 33% On SmileShop Patent News

Shares of SmileDirectClub Inc. (SDC) are surging over 33% in pre-market today, after the company announced that it has been granted a patent for its SmileShop intellectual property from the United States Patent & Trademark Office.

from RTT - Before the Bell https://ift.tt/3f8U5Vg
via IFTTT

Ecolab Says COVID-19 Impact Will Be Net Unfavorable On FY20 Results

While reporting its financial results for the first quarter on Tuesday, Ecolab Inc. (ECL) said it expects the major COVID-19 impacts will be felt over the next few quarters and will be net unfavorable on both its top and bottom lines for the year. However, the company said its forward earnings guidance remains suspended.

from RTT - Earnings https://ift.tt/2Sfd06V
via IFTTT

Coca-Cola European Partners Q1 Revenue Down 4% - Quick Facts

Coca-Cola European Partners plc or CCEP (CCE) reported Tuesday that its revenue for the first quarter of fiscal 2020 declined 4 percent from the year-ago period to 2.48 million euros.

from RTT - Earnings https://ift.tt/2Y8zDOa
via IFTTT

Nucor Expects To Report Loss In Q2 Amid COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Tuesday, steel and steel products maker Nucor Corp. (NUE) said it likely to report a loss in the second quarter of 2020 amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/3cVWKiW
via IFTTT

First Commonwealth Financial Q1 Results Miss Estimates - Quick Facts

First Commonwealth Financial Corp. (FCF) on Tuesday reported net income for the first quarter of $4.73 million or $0.05 per share, down sharply from $24.59 million or $0.25 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3cTeprv
via IFTTT

Iridium Communications Lowers FY20 Outlook Amid COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Tuesday, Iridium Communications Inc. (IRDM) lowers its total service revenue growth guidance for the full-year 2020, given the current global shutdown and macroeconomic uncertainties amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/2SfrvaZ
via IFTTT

S&P Global Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, S&P Global, Inc. (SPGI) slashed its earnings guidance for the full-year 2020, due to the uncertainties associated with COVID-19 outbreak.

from RTT - Earnings https://ift.tt/3aQEsys
via IFTTT

Sirius XM Withdraws FY20 Outlook; Plans To Resume Share Buybacks In Q2

While reporting its financial results for the first quarter on Tuesday, Sirius XM Holdings Inc. (SIRI) said it has withdrawn its full-year 2020 guidance for self-pay net subscriber additions, revenue, adjusted EBITDA and free cash flow first issued on January 7, 2020.

from RTT - Earnings https://ift.tt/3cSoaq0
via IFTTT

Merck Q1 Results Top Estimates; But Cuts 2020 Outlook

Merck & Co., Inc. (MRK) reported a profit for the first-quarter that increased 10 percent from last year. Quarterly sales increased 11 percent. The company lowered its full-year 2020 outlook, due to the impact of COVID-19.

from RTT - Earnings https://ift.tt/2yShbP2
via IFTTT

Novartis Benefited By COVID-19 Forward Purchasing; Sees Slowdown In Enrollments

Swiss drug major Novartis on Tuesday confirmed its fiscal 2020 outlook after its first-quarter earnings. Sales were benefited partly by increased forward purchasing and lower spending due to COVID-19. However, these impacts are expected to reverse in the rest of 2020. Novartis said the pandemic did not have a material impact on its underlying business in the quarter.

from RTT - Earnings https://ift.tt/3f4u3CD
via IFTTT

Corning Withdraws FY20 Outlook Due To COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Tuesday, Corning Inc. (GLW) said it is withdrawing its full-year 2020 guidance due to the economic uncertainty and disruption created by COVID-19.

from RTT - Earnings https://ift.tt/2y9I2Gi
via IFTTT

Roper Technologies Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, software developer Roper Technologies, Inc. (ROP) slashed its adjusted earnings guidance for the full-year 2020, and provided adjusted earnings outlook for the second quarter, below analysts' estimates.

from RTT - Earnings https://ift.tt/2W4zWa6
via IFTTT

Rockwell Automation Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the second quarter on Tuesday, Rockwell Automation, Inc. (ROK) slashed its adjusted earnings and sales guidance for the full-year 2020, based on the information currently available amid the uncertainties associated with the magnitude and duration of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2Y9L6gp
via IFTTT

Harley-Davidson Q1 Worldwide Retail Motorcycle Sales Down 17.7% - Quick Facts

While reporting financial results for the first quarter, Harley-Davidson, Inc. (HOG) reported Tuesday that its total worldwide retail motorcycle sales in the quarter were down 17.7 percent to 40,439 units from last year. Motorcycle shipments also declined 10.0 percent to 52,973 units from last year.

from RTT - Earnings https://ift.tt/2VLl3KR
via IFTTT

Relmada Therapeutics (RLMD): Sending The Right Signals?

Shares of Relmada Therapeutics Inc. (RLMD) have gained 19 percent so far this year and trade around $37.

from RTT - Biotech https://ift.tt/2WjEA4j
via IFTTT

3M Withdraws FY20 Outlook; Q1 Results Top Estimates - Quick Facts

While reporting financial results for the first quarter on Tuesday, 3M Co. (MMM) withdrew its previously communicated full-year 2020 guidance on January 28, 2020, due to COVID-19 impact and end-market uncertainty.

from RTT - Earnings https://ift.tt/35aOHMw
via IFTTT

PepsiCo Q1 Results Top View; Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

Snack and beverage giant PepsiCo Inc. (PEP) on Tuesday reported a decline in net income for the first quarter, reflecting higher expenses despite an 7.7 percent growth in revenues.

from RTT - Earnings https://ift.tt/2y4aM3e
via IFTTT

BP Q1 Underlying Replacement Cost Profit Declines YoY - Quick Facts

BP Plc (BP.L, BP_UN.TO, BP) reported a first quarter loss to shareholders of $4.365 billion, compared to profit of $2.934 billion, prior year. Loss per share in cents was 21.63 compared to profit of 14.47. Loss per ADS was $1.30 compared to profit of $0.87. Replacement cost loss for the first quarter was $0.6 billion, compared to profit of $2.1 billion, last year, including a $1.4 billion net adverse impact of non-operating items and fair value accounting effects. Underlying replacement cost profit was $0.8 billion, compared to $2.4 billion, last year. Underlying RC profit per ordinary share, in cents, was 3.92 compared to 11.69. Underlying RC profit per ADS $0.24 compared to $0.70. On average, eight analysts polled by Thomson Reuters expected the company to report profit per share of $0.26, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2Sd2OvK
via IFTTT

Novartis Q1 Core Profit Rises, Sales Up 11%; Confirms 2020 Guidance

Novartis (NVS) reported first quarter net income from continuing operations of $2.2 billion, an increase of 16%, or up 24% cc year-on-year, including higher legal provisions and taxes. Earnings per share was $0.96 compared to $0.81. Core operating income was $4.2 billion, growth of 28%, or up 34% cc, mainly driven by higher sales, benefiting from COVID-19 forward purchasing and gross margin improvement, partly offset by launch investments. Excluding COVID-19 related forward purchases and lower spending, the company estimates core operating income growth to be approximately 22% cc. Core earnings per share was $1.56 compared to $1.21. On average, six analysts polled by Thomson Reuters expected the company to report profit per share of $1.36, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2SfZi3D
via IFTTT

Cresco Labs Q4 Loss Widens; Terminates Acquisition Of Tryke Companies

Cresco Labs Inc. on Monday reported a net loss for the fourth quarter that widened from last year as higher costs and expenses offset strong revenue growth.

from RTT - Earnings https://ift.tt/3bPD8gA
via IFTTT

Biotech Stocks Facing FDA Decision In May 2020

So far this year, 16 novel drugs have received FDA approval compared to 9 which were greenlighted during the same period last year. Now, let's take a look at the biotech stocks that are awaiting a regulatory decision in May 2020.

from RTT - Biotech https://ift.tt/2KFfxTD
via IFTTT

Optimism About States Reopening May Generate Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/359W2Mp
via IFTTT

FDA Warns Of Risks Related To Use Of Anti-malaria Drugs For COVID-19

Though it issued an Emergency Use Authorization (EUA) for anti-malaria drugs to treat or prevent coronavirus (COVID-19), the U.S. Food and Drug Administration (FDA) reiterated its warning about the known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems.

from RTT - Biotech https://ift.tt/2VGf5e7
via IFTTT

Stock Alert: Arcturus Shares Up 15% In Premarket

Shares of Arcturus Therapeutics Holdings Inc. (ARCT) are rising above 15% in pre-market today, after the company reported positive immunogenicity data from its preclinical study for its COVID-19 Vaccine. These data for LUNAR-COV19 were measured by Duke-NUS Medical School in Singapore.

from RTT - Before the Bell https://ift.tt/2VWPOeI
via IFTTT

Stock Alert: Interpace Biosciences Stock Up 20% In Premarket

Shares of Interpace Biosciences Inc. (IDXG) are up 20% in pre-market today, after the company announced that its subsidiary, Interpace Diagnostics, has entered into a contract with Avalon Healthcare Solutions, a specialty benefit management company with more than 3 million members, focused on laboratory testing. Terms remain undisclosed.

from RTT - Before the Bell https://ift.tt/2W6DxEq
via IFTTT

Vossloh Q1 Preliminary EBIT Surges; Affirms FY20 Outlook - Quick Facts

German rail technology company Vossloh Group (VOSSF.PK) on Monday announced preliminary results for the first quarter of 2020.

from RTT - Earnings https://ift.tt/3aJ0xPf
via IFTTT

Avadel (AVDL) Soars On REST-ON Trial Results

Avadel Pharmaceuticals plc's (AVDL) pivotal phase III trial evaluating FT218 for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy has met its three co-primary efficacy endpoints at all three doses.

from RTT - Biotech https://ift.tt/3cXxjhf
via IFTTT

Stock Alert: Eltek Shares Up 20% On Q4 Results

Shares of Eltek Ltd. (ELTK) are rising over 20% in pre-market today, after the company reported stellar Q4 results.

from RTT - Before the Bell https://ift.tt/2Y6cpIt
via IFTTT

Stock Alert: Medigus Stock Up 28% In Premarket

Shares of Medigus Ltd. (MDGS) are rising over 28% in pre-market today, after the company announced the signing of a collaboration agreement with L-1 Systems Ltd. for the joint commercialization of various COVID-19 related products and solutions to governmental agencies and institutional healthcare organizations.

from RTT - Before the Bell https://ift.tt/3cSlFEd
via IFTTT

Stock Alert: Avadel Pharma Up 37% In Premarket

Shares of Avadel Pharmaceuticals plc (AVDL) are soaring over 37% in pre-market today, after the company announced positive topline data from its pivotal Phase 3 REST-ON trial assessing the safety and efficacy of FT218, an investigational, once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.

from RTT - Before the Bell https://ift.tt/2yS8nsr
via IFTTT

Lincoln Electric Q1 Profit Declines, Meets View - Quick Facts

Lincoln Electric Holdings, Inc. (LECO) reported Monday that net income for the first quarter declined to $55.56 million or $0.91 per share from $71.48 million or $1.12 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2KzODg3
via IFTTT

CMS Energy Maintains FY20 Earnings Outlook - Quick Facts

While reporting its financial results for the first quarter on Monday, CMS Energy Corp. (CMS) said it is not changing its guidance for 2020 adjusted earnings of $2.64 to $2.68 per share, as announced on January 30, as the ultimate impacts of the pandemic on Michigan's economy and the company's business remain uncertain.

from RTT - Earnings https://ift.tt/3cQJgVF
via IFTTT

RedHill Biopharma Provides Update On Compassionate Use Program With Opaganib

Biopharmaceutical company RedHill Biopharma Ltd. (RDHL) on Monday provided an additional update on the compassionate use program with its investigational drug, opaganib (Yeliva, ABC294640)1, in patients with confirmed SARS-CoV-2 infection (the cause of COVID-19) in Israel.

from RTT - Biotech https://ift.tt/2VG4K1N
via IFTTT

Sutro Biopharma Reports Updated Data From Ovarian Cancer Study

Sutro Biopharma Inc.'s (STRO) interim phase I updated clinical data for a dose-escalation study of antibody drug-conjugate STRO-002 in ovarian cancer has been encouraging.

from RTT - Biotech https://ift.tt/2zslq4a
via IFTTT

Axsome Therapeutics (AXSM) Advances To Cross $100-Mark

Axsome Therapeutics Inc.'s (AXSM) phase II/III trial of investigational drug AXS-05 in Alzheimer's disease agitation has met the primary endpoint.

from RTT - Biotech https://ift.tt/2KC5SgP
via IFTTT

Stock Alert: AudioCodes Stock Up 10% In Premarket On Upbeat Q1

Shares of AudioCodes Ltd. (AUDC) are rising over 10% in pre-market today, after the company reported better-than-expected Q1 results.

from RTT - Before the Bell https://ift.tt/2xd6Ixp
via IFTTT

Axsome Therapeutics (AXSM) Advances To Cross $100-Mark

Axsome Therapeutics Inc.'s (AXSM) phase II/III trial of investigational drug AXS-05 in Alzheimer's disease agitation has met the primary endpoint.

from RTT - Before the Bell https://ift.tt/2KC5SgP
via IFTTT

Check Point Software Q1 Results Top View - Quick Facts

Cyber security solutions provider Check Point Software Technologies Ltd. (CHKP) reported Monday that its net income for the first quarter was $178.7 million or $1.23 per share, compared to $179.9 million or $1.15 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2YbIs9Q
via IFTTT

Deutsche Bank Sees Q1 Results Above Market View

Deutsche Bank AG (DB) said Sunday that it expects to report first-quarter group profit before tax of 206 million euros and net income of 66 million euros, above market expectations.

from RTT - Earnings https://ift.tt/2VTRAwY
via IFTTT

Stock Alert: Intel Down 3% On Uncertain Outlook

Shares of Intel Corp. (INTC) are losing more than 3 percent or $1.80 in Friday's morning trade at $57.24. The chipmaker forecast a profit for the second quarter lower than analysts' estimates. Intel also did not provide full-year guidance due to the significant economic uncertainty related to the coronavirus pandemic.

from RTT - Earnings https://ift.tt/2S5hRr5
via IFTTT

Verizon Q1 Profit Tops View, But Revenues Miss; Cuts 2020 Profit Outlook

Verizon Communications Inc. (VZ) on Friday reported a 17.4 percent decline in profit for the first-quarter from last year. Quarterly operating revenues also decreased 1.6 percent. The company cut 2020 earnings outlook and withdrew revenue guidance as the coronavirus pandemic impacted its businesses.

from RTT - Earnings https://ift.tt/2yIWeX2
via IFTTT

Sanofi Q1 Profit Climbs; Backs FY20 Earnings Growth View

Shares of Sanofi SA (SNYNF) were gaining around 2 percent in Paris trading after the French drug maker reported higher profit in its first quarter with strong sales growth mainly from Dupixent, as well as COVID-19 impact. Looking ahead for fiscal 2020, Sanofi continues to expect business earnings per share to grow around 5 percent at constant exchange rates.

from RTT - Earnings https://ift.tt/3bGg8k4
via IFTTT

Freeport-McMoRan Q1 Adj. Loss Narrower Than Estimates; Revenues Miss View

Freeport-McMoRan Inc. (FCX) on Friday reported its first-quarter 2020 financial results and revised operating plans in response to the global COVID-19 pandemic and the resulting negative impact on the global economy. The company's adjusted loss per share for the quarter was narrower than analysts' expectations, while revenues missed their estimates.

from RTT - Earnings https://ift.tt/2VTzLhR
via IFTTT

Stock Alert: Pluristem Therapeutics Stock Up 16% In Premarket

Shares of Pluristem Therapeutics Inc. (PSTI) are rising over 16% in pre-market today, after the company announced that the European Investment Bank has approved a ?50 million non-dilutive financing for the company.

from RTT - Before the Bell https://ift.tt/3aB64Ya
via IFTTT

Stock Alert: Mesoblast Shares Jump 67% In Premarket

Shares of Mesoblast Ltd. (MESO) are soaring over 67% in pre-market today, after the company announced 83% survival in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome or ARDS treated during the period March-April 2020 with two intravenous infusions of Mesoblast's allogeneic mesenchymal stem cell product candidate remestemcel-L within the first five days.

from RTT - Before the Bell https://ift.tt/3534HQO
via IFTTT

SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch

Today's Daily Dose brings you news about Cassava Sciences' research grant from the National Institutes of Health for developing Alzheimer's disease drug; Edwards Lifesciences' Q1 financial results; Enzo Biochem's launch of the next-generation COVID-19 test kits and Johnson & Johnson's deal with Emergent BioSolutions related to COVID-19 Vaccine candidate.

from RTT - Biotech https://ift.tt/34ZOmw4
via IFTTT

Stock Alert: Las Vegas Sands Rises 9%

Shares of Las Vegas Sands Corp. (LVS) are rising more than 9 percent or $3.95 in Thursday's trading at $44.98 despite the company reporting financial results for the first quarter that missed analyst's expectations. The stock has traded in a range of $33.30 to $74.29 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3cGdmuX
via IFTTT

Stock Alert: CNS Pharmaceuticals Stock Up 7% In Premarket

Shares of CNS Pharmaceuticals Inc. (CNSP) are rising over 7% in pre-market today, after the company announced that it has filed an application with the U.S. FDA to receive Orphan Drug Designation or ODD for its lead product Berubicin.

from RTT - Before the Bell https://ift.tt/3cG80Qn
via IFTTT

Stock Alert: Enzo Biochem Shares Jump 28% In Early Trading

Shares of Enzo Biochem Inc. (ENZ) are rising over 28% in pre-market today, after the company announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo's ELISA platform, and a promising proprietary drug candidate (SK1-I).

from RTT - Before the Bell https://ift.tt/3cFyD87
via IFTTT

NVR Says COVID-19 Pandemic Has Significant Impact On Business - Quick Facts

While reporting its financial results for the first quarter on Thursday, NVR Inc. (NVR), homebuilding and mortgage banking company, said the COVID-19 pandemic has had a significant impact on all facets of its business.

from RTT - Earnings https://ift.tt/2VwVE7K
via IFTTT

Futures Pointing To Roughly Flat Open On Wall Street

The major U.S. index futures are currently pointing to a roughly flat opening on Thursday, with stocks likely to show a lack of direction following the volatility seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2S15koR
via IFTTT

Stock Alert: Fluidigm Shares Surge 13% In Premarket

Shares of Fluidigm Corp. (FLDM) are soaring over 13% in pre-market today, after the company announced that OU Medicine, the University of Oklahoma and the Oklahoma Medical Research Foundation or OMRF intend to utilize Fluidigm microfluidics technology and certain reagents to test individuals for the SARS-CoV-2 virus, which causes COVID-19.

from RTT - Before the Bell https://ift.tt/2KrW8FB
via IFTTT

Stock Alert: CounterPath Shares Spike 85% In Premarket

Shares of CounterPath Corp. (CPAH) surged over 85% in premarket today, after the company announced that it is experiencing a strong demand for its products and services due to the COVID-19 global public health emergency.

from RTT - Before the Bell https://ift.tt/3eN4A00
via IFTTT

CTS Withdraws FY20 Outlook Amid COVID-19; Q1 Results Top Estimates - Quick Facts

While reporting financial results for the first quarter on Thursday, CTS Corp. (CTS) said it is withdrawing its financial guidance for the full year 2020, and is not providing updated guidance at this time, due to ongoing market uncertainties amid the coronavirus (COVID-19) outbreak.

from RTT - Earnings https://ift.tt/2VTbeJA
via IFTTT

EQT Corp. Reports Q1 Preliminary Sales Volume Exceeding High End Of Range

EQT Corp. (EQT) on Thursday provided certain preliminary first quarter 2020 operational and financial highlights, along with an update on its outlook and deleveraging plan. The company said it has experienced limited operational impacts as a result of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3cDj8xB
via IFTTT

W.W. Grainger Suspends FY20 Outlook; Pauses Share Repurchases - Quick Facts

While reporting financial results for the first quarter on Thursday, W.W. Grainger, Inc. (GWW) said it is suspending its financial guidance for the full year 2020 and pausing share repurchases given the uncertainties surrounding the ongoing coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/2XZOOZO
via IFTTT

Alliance Data Suspends FY20 Outlook Amid COVID-19; Declared Quarterly Dividend

While reporting its financial results for the first quarter on Thursday, Alliance Data Systems Corp. (ADS) said it is suspending its previous financial guidance for the full year 2020 as it is difficult to project the duration of this pandemic and its impact on full-year results.

from RTT - Earnings https://ift.tt/2x4Z7Rq
via IFTTT

Domino's Pizza Withdraws Two- To Three-year Outlook Due To COVID-19

While reporting its financial results for the first quarter on Thursday, Domino's Pizza Inc. (DOM.L, DPZ) said it is withdrawing its two-to three-year outlook for global retail sales growth, U.S. same store sales growth, international same store sales growth and global net unit growth.

from RTT - Earnings https://ift.tt/2S1zsjN
via IFTTT

Ocean Spray Recalls Pink Lite Cranberry Juice For Undeclared Sulfites

Ocean Spray Cranberries, Inc. is recalling Pink Lite Cranberry Juice Drink citing potential for undeclared sulfites, the U.S. Food and Drug Administration said in a statement. The recall involves a single production lot of 5.5oz cans of the drink with lot number MH0030LPK4 and Best Before Date of 24JAN21. The product is sold in boxes containing six 5.5oz cans. They were distributed to retail

from RTT - Biotech https://ift.tt/2RVrKrt
via IFTTT

Tractor Supply Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, rural lifestyle retailer Tractor Supply Co. (TSCO) said it is withdrawing its financial guidance for fiscal 2020 provided on April 7, 2020, given the uncertainty related to the coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/2VuHfZo
via IFTTT

Pool Slashes FY20 Adj. Earnings Outlook; Boosts Dividend 5% - Quick Facts

While reporting financial results for the first quarter, swimming pool distributor Pool Corp. (POOL) on Thursday slashed its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2zpmIgt
via IFTTT

Eli Lilly Q1 Results Top Estimates; Lifts 2020 Profit View

Eli Lilly and Co. (LLY) on Thursday reported a 66 percent decline in profit for the first-quarter from last year, reflecting the gain recognized on the disposition of Elanco Animal Health in the prior year. But, quarterly revenue increased 15 percent, driven by 22 percent volume growth. The company raised its profit outlook for fiscal year 2020, but it maintained annual revenue guidance.

from RTT - Earnings https://ift.tt/3eO7B0q
via IFTTT

Reliance Steel Suspends Financial Outlook, But Declares Dividend - Quick Facts

While reporting financial results for the first quarter on Thursday, metals services company Reliance Steel & Aluminum Co. (RS) said it will not provide guidance for the second quarter ending June 30, 2020 at this time, due to the macroeconomic uncertainty stemming from the coronavirus (COVID-19) pandemic and overall lack of visibility into future demand trends, metal pricing and market conditions in the end markets in which Reliance operates.

from RTT - Earnings https://ift.tt/2zoMSjq
via IFTTT

MarineMax Q1 Results Top Estimates - Quick Facts

Recreational boat and yacht retailer MarineMax Inc. (HZO) reported Thursday that net income for the second quarter was $5.1 million or $0.23 per share, compared to $5.3 million or $0.23 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2zhpy70
via IFTTT

Credit Suisse Q1 Profit Climbs, Warns On Covid-19 Impacts; Stock Down

Shares of Credit Suisse Group AG were losing around 3 percent in Swiss trading after the banking major cautioned Thursday about further uncertainties resulting from the COVID-19 pandemic, despite reporting significant profit growth in the first quarter. Going ahead, Credit Suisse said the pandemic and the consequences for markets and the global economy, at least in the first half of 2020, is ..

from RTT - Earnings https://ift.tt/3by5MCu
via IFTTT

Arch Coal Suspends FY20 Sales Volume Guidance, Dividend - Quick Facts

While reporting financial results for the first quarter on Thursday, coal producer Arch Coal, Inc. (ARCH) said it is suspending its total sales volume outlook for the full year 2020, given the current market uncertainty amid the coronavirus (COVID-19) outbreak.

from RTT - Earnings https://ift.tt/2xRtATl
via IFTTT

Anglo American Q1 Copper Production Down 9%; Reduces FY20 Capex Guidance

Anglo American plc (AAUKY.PK, AAL.L) reported Thursday that its copper production for the first quarter declined 9 percent from last year to 147,000 tonnes, largely due to an expected reduction at Los Bronces, driven by the continued drought conditions in central Chile. This was partially offset by continued strong plant performance at Collahuasi.

from RTT - Earnings https://ift.tt/3aumxNF
via IFTTT

Rexel Q1 Sales Down 2.7%; To Cut CEO Base Salary, Board Members' Compensation

Rexel (RXLSF.PK), a French distributor of electrical supplies, reported Thursday that its sales for the first quarter of 2020 declined 2.7 percent year-on-year on a reported basis to 3.225 billion euros. On a constant and same-day basis, sales for the quarter decreased 3.3 percent after a strong start to the year.

from RTT - Earnings https://ift.tt/2KvkNZO
via IFTTT

IMMU Gets Early FDA Nod, KNSA's PN Trial Meets Goals, MYOV In Good Spirits

Today's Daily Dose brings you news about FDA approval of Immunomedics' breast cancer drug; promising results from Kiniksa Pharma's prurigo nodularis trial; Mallinckrodt's regulatory catalyst; Myovant Sciences' phase III SPIRIT 2 study results and another disappointment in Parkinson's disease drug development space.

from RTT - Biotech https://ift.tt/2XXBZz7
via IFTTT

Stock Alert: Peck Company Shares Surge 55% In Premarket

Shares of The Peck Company Holdings Inc. (PECK) are rising over 55% in pre-market today, after the company a new investment partnership tailored to increase Peck's access to capital for the construction of new solar projects and to scale its existing pipeline of new EPC business.

from RTT - Before the Bell https://ift.tt/2yxQe35
via IFTTT

Stock Alert: Myovant Sciences Stock Up 4% In Premarket

Shares of Myovant Sciences Ltd. (MYOV) are rising over 4% in pre-market today, after the company announced that SPIRIT 2, the first of two Phase 3 studies of once-daily relugolix combination therapy in women with pain associated with endometriosis, met its co-primary efficacy endpoints and six key secondary endpoints.

from RTT - Before the Bell https://ift.tt/2VwKqjD
via IFTTT

Amphenol Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Wednesday, Amphenol Corp. (APH) announced that it is withdrawing its full-year 2020 sales and earnings guidance, and will not be providing a specific outlook for the second quarter as the overall demand and operating environment remains highly uncertain due to the coronavirus (COVID-19) outbreak.

from RTT - Earnings https://ift.tt/2yzu00N
via IFTTT

Interpublic Q1 Adj. Earnings Top Estimates - Quick Facts

Interpublic Group of Cos, Inc. (IPG) on Wednesday reported net income available to IPG common stockholders for the first quarter of $4.7 million or $0.01 per share, compared to a loss of $8.0 million or $0.02 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3cJTibn
via IFTTT

AT&T Q1 Profit Tops View, But Revenues Miss

AT&T Inc. (T) reported a profit for the first-quarter that increased 11.8 percent from last year, while quarterly operating revenues declined 4.6 percent. Adjusted earnings per share topped analysts' expectations, but quarterly revenues missed their estimates.

from RTT - Earnings https://ift.tt/3auUwpl
via IFTTT

Kimberly-Clark Withdraws FY20 Outlook; Suspends Share Buyback Program

While reporting its financial results for the first quarter on Wednesday, Kimberly-Clark Corp. (KMB) said it is withdrawing its previous guidance for fiscal 2020 and not providing any additional outlook at this time.

from RTT - Earnings https://ift.tt/2KrFINs
via IFTTT

Biogen Q1 Results Top Estimates - Quick Facts

Biogen Inc. (BIIB) on Wednesday reported net income attributable to the company for the first quarter of $1.40 billion or $8.08 per share, up from $1.41 billion or $7.15 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/34THRee
via IFTTT

Stock Alert: BioNTech Shares Climb 48% In Early Trading

Shares of BioNTech SE (BNTX) are surging over 48% in pre-market today, after the company and Pfizer Inc. (PFE) announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech's BNT162 vaccine program to prevent COVID-19 infection.

from RTT - Before the Bell https://ift.tt/2XTXu3R
via IFTTT

Will These Pharma Stocks Hit Or Miss Trial Goals? (ITRM, STRO, ENTA)

Let's take a look at the biotech/pharma companies that are slated to report clinical trial results this quarter.

from RTT - Biotech https://ift.tt/2x1XrrS
via IFTTT

Teledyne Technologies Slashes FY20 Earnings Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, Teledyne Technologies Inc. (TDY) slashed its earnings guidance for fiscal 2020 to a range of $9.30 to $10.00 per share from the prior forecast range of $11.20 to $11.30 per share.

from RTT - Earnings https://ift.tt/3amWLLi
via IFTTT

Wolverine World Wide Q1 Adj. EPS Tops View, But Revenues Miss - Quick Facts

Wolverine World Wide, Inc. (WWW) on Wednesday reported net earnings attributable to the company for the first quarter of $13.0 million or $0.16 per share, down from $40.5 million or $0.40 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3bvxpw1
via IFTTT

LIFE In COVID-19 Battle, LH On Watch, CARA Keeps KALM, All Eyes On MYOV

Today's Daily Dose brings you news about aTyr Pharma joining the COVID-19 battle; Cara's pivotal KALM-2 trial; LabCorp's at-home collection kit for COVID-19 testing securing Emergency Use Authorization from the FDA, and Myovant's much-awaited clinical trial catalyst.

from RTT - Biotech https://ift.tt/2VtNtsF
via IFTTT

Worries About Crude Oil Prices May Weigh On Wall Street

The major U.S. index futures are currently pointing to a sharply lower open on Tuesday, with stocks likely to extend the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/3axd8Fj
via IFTTT

Stock Alert: Cara Therapeutics Stock Up 15% In Premarket

Shares of Cara Therapeutics Inc. (CARA) are rising above 15% in pre-market today, following the company's announcement of positive results from global KALM-2 pivotal phase 3 trial of KORSUVATM injection in Hemodialysis patients with Pruritus.

from RTT - Before the Bell https://ift.tt/2zjTHTo
via IFTTT

PolarityTE Projects Fall In Q1 SkinTE Revenue Due To COVID-19 - Quick Facts

PolarityTE, Inc. (PTE), a biotechnology company developing regenerative tissue products and biomaterials, on Tuesday provided preliminary first-quarter results and also provided an update on actions it is taking in light of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2RSRZyQ
via IFTTT

ManpowerGroup Q1 Profit Down 96.8%, Revenue Declines - Quick Facts

ManpowerGroup Inc. (MAN), a provider of workforce solutions, on Tuesday reported net earnings for the first quarter of $1.7 million or $0.03 per share, down sharply from $53.5 million or $0.88 per share in the prior-year period. The company's shares are losing almost 5 percent in pre-market activity.

from RTT - Earnings https://ift.tt/2Kz9Dnf
via IFTTT

LabCorp's COVID-19 At-Home Test Kit Receives EUA From FDA - Quick Facts

Life sciences company LabCorp (LH) announced Tuesday that it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 at-home test kit.

from RTT - Biotech https://ift.tt/2zbOFYS
via IFTTT

Snap-On Q1 Results Miss Estimates - Quick Facts

Snap-On, Inc. (SNA) reported Tuesday first-quarter net earnings of $137.2 million or $2.49 per share, down from $177.9 million or $3.16 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2Vo7SiE
via IFTTT

Coca-Cola Q1 Results Top Estimates

Coca-Cola Co. (KO) reported a profit for the first-quarter that increased 65 percent from the previous year. But, quarterly net revenues declined 1 percent. Both adjusted earnings per and quarterly revenues topped analysts' expectations.

from RTT - Earnings https://ift.tt/3czD8B5
via IFTTT

SAP Posts Profit, Backs FY20 View; Co-CEO Jennifer Morgan To Leave; Stock Dips

German software major SAP SE reported Tuesday a profit in its first quarter, compared to last year's loss with good growth in revenues. Going ahead, the company maintained its fiscal 2020 outlook. The company late Monday announced the departure of Co-CEO Jennifer Morgan in April end, as the firm simplifies its leadership structure amid the coronavirus pandemic.

from RTT - Earnings https://ift.tt/3bpLMCd
via IFTTT

CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19

Today's Daily Dose brings you news about Bristol-Myers' CheckMate -743 study results; Cyclacel Pharma's entry into COVID-19 drug bandwagon; Exelixis touching a new 52-week high and Novartis exploring anti-malaria drug for COVID-19.

from RTT - Biotech https://ift.tt/2VsxxHj
via IFTTT

Stock Alert: Exelixis Stock Up 19% In Premarket

Shares of Exelixis Inc. (EXEL) are soaring over 19% in pre-market today, after the company and Bristol Myers Squibb (BMY) announced that CheckMate -9ER, a pivotal Phase 3 trial evaluating Opdivo (nivolumab) in combination with CABOMETYX (cabozantinib) compared to sunitinib in previously untreated advanced or metastatic renal cell carcinoma or RCC, met its primary endpoint of progression-free survival or PFS at final analysis, as well as the secondary endpoints of overall survival at a pre-specified interim analysis, and objective response rate.

from RTT - Before the Bell https://ift.tt/2RUpb8Z
via IFTTT

Stock Alert: Anixa Shares Up 18% In Premarket

Shares of Anixa Biosciences Inc. (ANIX) are rising over 18% in pre-market today, after a strategic collaboration with OntoChem GmbH to discover and develop anti-viral drug candidates for COVID-19.

from RTT - Before the Bell https://ift.tt/2zh73zJ
via IFTTT

FDA Approves First Targeted Treatment For Bile Duct Cancer

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Incyte Corp.'s Pemazyre (pemigatinib) as the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma, a cancer of bile ducts. While approving Pemazyre, the FDA considered the overall risk to benefit assessment for patients with tumors harboring FGFR2 gene fusions.

from RTT - Biotech https://ift.tt/3bAfqEZ
via IFTTT

Stock Alert: Cyclacel Pharma Shares Up 53% In Premarket

Shares of Cyclacel Pharmaceuticals Inc. (CYCC) are surging over 53% in pre-market today, after the company announced an agreement with the University of Edinburgh to study fadraciclib (CYC065) and seliciclib (CYC202 or R-roscovitine), its clinical stage CDK2/9 inhibitors, as potential early treatments for the inflammatory response observed in patients with COVID-19 disease.

from RTT - Before the Bell https://ift.tt/3eEGdBF
via IFTTT

Philips Q1 Orders Up, Sees Growth In FY20 Comparable Sales, Margin; Stock Up

Shares of Philips Electronics NV were gaining around 7 percent in Dutch trading after the consumer electronics giant reported strong growth in orders in the first quarter and said it sees modest comparable sales growth in fiscal 2020, despite the significant impact from the coronavirus or COVID-19 pandemic. First-quarter net profit, meanwhile, plunged from last year hurt by COVID-19.

from RTT - Earnings https://ift.tt/2Km4deV
via IFTTT

Stock Alert: Safe-T Group Shares Up 35% In Premarket

Shares of Safe-T Group Ltd (SFET) are rising over 35% in pre-market today, following the company's strong Q1 revenue outlook.

from RTT - Before the Bell https://ift.tt/2VGmo4w
via IFTTT

Lennox International Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Monday, Lennox International Inc. (LII) slashed its earnings and revenue growth outlook for the full-year 2020, based on current market assumptions.

from RTT - Earnings https://ift.tt/3bqE8Y7
via IFTTT

This Day That Year: HOOKIPA Pharma (HOOK)

Shares of HOOKIPA Pharma Inc. (HOOK) are down 44 percent from their 52-week high of $14.38, recorded last April, and trade around $8.

from RTT - Biotech https://ift.tt/2VlhiLM
via IFTTT

Amazon investment in Deliveroo 'cleared' by UK watchdog

Delivery firm warned it could go bust without investment given so many restaurants it uses have shut due to coronavirus

UK competition authorities have provisionally cleared Amazon’s investment in Deliveroo after the takeaway delivery firm warned it could collapse because of the coronavirus crisis.

The takeaway firm told the Competition and Markets Authority it had suffered a “significant decline in revenues” since the government lockdown to limit the spread of the virus closed many of the restaurants it dealt with. Efforts to step up grocery deliveries had not offset the loss of trade from restaurants, it said.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/3anvp7X

Stock Alert: Lovesac Company Climbs 20%

Shares of Lovesac Co. (LOVE) are climbing almost 20 percent or $1.49 in Friday's trading at $9.00. The stock has traded in a range of $3.99 to $46.79 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2VzES6I
via IFTTT

Optimism About Coronavirus Treatment May Generate Initial Buying Interest

The major U.S. index futures are currently pointing to a sharply higher opening on Friday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/2VzRWZz
via IFTTT

Kansas City Southern Withdraws Earnings Guidance Due To COVID-19 - Quick Facts

While reporting its financial results for the first quarter on Friday, Kansas City Southern (KSU) said it is withdrawing its previously provided outlook for revenue, volume, operating ratio and earnings per share due to the general economic uncertainty created by the global COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3aiUnoN
via IFTTT

Procter & Gamble Backs FY20 Core EPS Growth Outlook - Quick Facts

While reporting financial results for the third quarter on Friday, consumer goods giant Procter & Gamble Co. (PG) maintained its full-year 2020 guidance for core earnings per share growth and organic sales growth, while trimming its outlook for all-in sales growth for the year, reflecting stronger headwinds from foreign exchange.

from RTT - Earnings https://ift.tt/2wNeJJd
via IFTTT

Revisiting BioXcel Therapeutics (BTAI)

Shares of BioXcel Therapeutics Inc. (BTAI) have gained nearly 86 percent over the last 1 month as the Company gears up for reporting trial results of one of its most advanced clinical development programs BXCL501.

from RTT - Biotech https://ift.tt/2wPG3GI
via IFTTT

Stock Alert: Inspired Entertainment Shares Soar 35% In Pre Market

Shares of Inspired Entertainment Inc. (INSE) are surging over 35% in pre-market today, following the company's contract with DraftKings to provide its new V-Play Plug & Play solution, a complete end-to-end online virtual sportsbook product that allows DraftKings to access Inspired's Virtual Sports with minimal integration effort and rapid speed-to-market.

from RTT - Before the Bell https://ift.tt/2RJpGmn
via IFTTT

Stock Alert: Moderna Shares Up 21% In Pre Market

Shares of Moderna Inc. (MRNA) are rising over 21% in pre-market today, after the company announced an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development Authority or BARDA to accelerate development of the company's mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2).

from RTT - Before the Bell https://ift.tt/3btfm9C
via IFTTT

BTAI On Track To Report SERENITY Data, REGN Hits All-time High, THMO On Watch

Today's Daily Dose brings you news about BioXcel's near-term catalyst; validation of Co-Diagnostics' CoPrimer technology for use with saline oral rinse samples; Regeneron Pharma's regulatory catalyst; and FDA allowing ThermoGenesis' SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit for distribution.

from RTT - Biotech https://ift.tt/2VeDh75
via IFTTT

Moderna Gets BARDA Award For $483 Mln To Speed Up COVID-19 Vaccine Development

Shares of Moderna Inc. (MRNA) are up more than 21 percent in extended trading on Thursday after the Biomedical Advanced Research and Development Authority (BARDA) committed up to $483 million to accelerate the development of the Company's mRNA vaccine candidate mRNA-1273 against the novel coronavirus.

from RTT - Biotech https://ift.tt/3agBIK4
via IFTTT

Stock Alert: Soligenix Stock Up 45% In Pre Market

Shares of Soligenix Inc. (SNGX) are soaring over 45% in pre-market today, after the company announced an agreement for the exclusive worldwide license of CoVaccine HT, a novel vaccine adjuvant, from BTG Specialty Pharmaceuticals, a division of Boston Scientific Corp. (BSX), for the fields of SARS-CoV-2, the cause of COVID-19 and pandemic flu.

from RTT - Before the Bell https://ift.tt/2XGbiPB
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Thursday, with stocks likely to regain some ground following the sharp pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2RH61Dy
via IFTTT

Stock Alert: Edison Nation Shares Climb 166% In Pre Market

Shares of Edison Nation Inc. (EDNT) are surging over 166% in pre-market today, after the company announced that it has received over $10 million in orders for the purchase of personal protective equipment during its first week since launch.

from RTT - Before the Bell https://ift.tt/2XHHzFF
via IFTTT

Amneal Pharma Recalls Certain Lots Of Nizatidine Oral Solution

Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Nizatidine in the form of oral solution for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels established by the U.S. Food and Drug Administration or FDA. The Bridgewater, New Jersey-based generic and specialty pharma company is recalling three lots of Nizatidine oral solution 15 mg.

from RTT - Biotech https://ift.tt/2XGcyC0
via IFTTT

Abbott Laboratories Q1 Adj. Earnings Beat View; Suspends FY20 Outlook

Medical devices and healthcare company Abbott Laboratories (ABT) on Thursday reported a 16 percent decline in profit for the first quarter from last year as an increase in sales was offset by higher operating costs and expenses, while the year-ago period's results were boosted by a tax benefit. However, adjusted earnings per share for the quarter beat analysts' estimates.

from RTT - Earnings https://ift.tt/2ylXoas
via IFTTT

Morgan Stanley Q1 Profit Down 32%; Results Miss Estimates - Quick Facts

Financial services firm Morgan Stanley (MS) on Thursday reported first-quarter net income applicable to the company's shareholders of $1.59 billion or $1.01 per share, down from $2.34 billion or $1.39 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/2VaDgB8
via IFTTT

Volkswagen Reports Prelim. Q1 Results; Withdraws 2020 Outlook - Quick Facts

Volkswagen AG (VKW.L, VLKAF.PK, VOW.BE) announced, based on preliminary figures, for the first quarter, the company projects: operating profit of 0.9 billion euros; and sales revenue of around 55 billion euros. The automotive net cash flow amounted to a negative 2.5 billion euros. Automotive net liquidity amounted to 17.8 billion euros.

from RTT - Earnings https://ift.tt/2XHncsm
via IFTTT

Rite Aid Maintains FY21 Outlook Despite COVID-19 Outbreak - Quick Facts

While reporting financial results for the fourth quarter on Thursday, drugstore chain Rite Aid Corp. (RAD) maintained its earnings and revenue guidance for the full year 2021 as the company does not have enough information at this time about the ultimate impact of COVID-19 on fiscal 2021 results to justify changing guidance.

from RTT - Earnings https://ift.tt/2RECWbB
via IFTTT

Sonoco Products Withdraws FY20 Outlook; Guides Q2 EPS Below Estimates

While reporting financial results for the third quarter on Thursday, packaging company Sonoco Products Co. (SON) announced it has withdrawn its full-year 2020 guidance for base earnings, cash flow from operations and free cash flow due to the unknown severity and duration of the COVID-19 pandemic and the related lack of visibility to the impact on the company's served markets.

from RTT - Earnings https://ift.tt/2XFgnY9
via IFTTT

BNY Mellon Declares Dividend Of $0.31 Per Share - Quick Facts

The Bank of New York Mellon Corp. (BK) announced Thursday that its Board of Directors authorized dividend on its common stock of $0.31 per share, payable on May 11, 2020 to shareholders of record as of the close of business on April 28, 2020.

from RTT - Earnings https://ift.tt/2K81h5s
via IFTTT

BlackRock Q1 Profit Declines, But Results Top Estimates, Boosts Qtly Dividend

BlackRock, Inc. (BLK) reported that its first-quarter net earnings declined to $806 million or $5.15 per share from $1.05 billion or $6.61 per share in the year-ago quarter. Excluding items, adjusted net income was $1.03 billion or $6.60 per share.

from RTT - Earnings https://ift.tt/34DnfHa
via IFTTT

RCUS Abuzz, FDA Approves First Therapy For LG UTUC, VNDA Joins COVID-19 Battle

Today's Daily Dose brings you news about Gilead reportedly mulling a stake in Arcus; disappointing results of Oragenics' oral mucositis trial; FDA approval of the first therapy for low-grade upper tract urothelial cancer and Vanda initiating a phase III trial in the treatment of neurogenic inflammation of the lung secondary to COVID-19.

from RTT - Biotech https://ift.tt/2VvbuhW
via IFTTT

Stock Alert: Comstock Holding Companies Skyrockets 267%

Shares of Comstock Holding Companies Inc. (CHCI) are skyrocketing more than 267 percent in Wednesday's trading at $5.66 after the company reported a turnaround to profit in fiscal 2019.

from RTT - Earnings https://ift.tt/3enPJsT
via IFTTT

Stock Alert: Muscle Maker Shares Up 20% In Pre-Market

Shares of Muscle Maker Inc. (GRIL) are rising over 20% in pre-market today, after the company announced the launch of grocery bundles to take convenience and safety to the next level while providing healthy meal options to patrons amid the COVID-19 pandemic.

from RTT - Before the Bell https://ift.tt/3aeKw3g
via IFTTT

Disappointing Earnings, Economic New May Weigh On Wall Street

The major U.S. index futures are pointing to a sharply lower open on Wednesday, with stocks likely to give back ground following the rally seen in the previous session.

from RTT - Market Analysis https://ift.tt/2K8wZ2I
via IFTTT

Citigroup Q1 Profit Beats Estimates - Quick Facts

Citigroup Inc. (C) reported first quarter earnings per share of $1.05 compared to $1.87, prior year. On average, 19 analysts polled by Thomson Reuters expected the company to report profit per share of $1.04, for the quarter. Analysts' estimates typically exclude special items. Net income was $2.5 billion, declined 46% driven by the higher cost of credit, partially offset by the higher revenues and a lower effective tax rate.

from RTT - Earnings https://ift.tt/2wF0Axt
via IFTTT

Goldman Sachs Q1 Profit Nearly Halves

Goldman Sachs Group Inc. (GS) reported a profit for the first-quarter that dropped 49 percent from the prior year, reflecting higher provision for credit losses. Quarterly revenue declined 1 percent.

from RTT - Earnings https://ift.tt/3bhrCdC
via IFTTT

Stock Alert: Applied DNA Sciences Stock Up 70% In Pre-Market

Shares of Applied DNA Sciences Inc. (APDN) are soaring over 70% in pre-market today, after the company announced the completion of design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-based Takis Biotech, a developer of cancer vaccines and the company's COVID-19 vaccine development partner, to support preclinical animal testing that will begin immediately.

from RTT - Before the Bell https://ift.tt/3es5uiG
via IFTTT

Bank Of America Q1 Profit Plunges, Results Miss Estimates - Quick Facts

Bank of America Corp. (BAC) reported Wednesday a profit for the first quarter that plunged from last year, hurt by sharply higher provision for credit losses predominantly driven by COVID-19 related reserve build. Both earnings per share and revenue for the quarter missed analysts' expectations.

from RTT - Earnings https://ift.tt/2wGo4Cx
via IFTTT

U.S. Bancorp Q1 Profit Tops Estimates - Quick Facts

U.S. Bancorp (USB) reported first quarter earnings per common share of $0.72 compared to $1.00, previous year. On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $0.58, for the quarter. Analysts' estimates typically exclude special items. Net income attributable to U.S. Bancorp was $1.17 billion, 31.1 percent lower from prior year.

from RTT - Earnings https://ift.tt/3bnbMOg
via IFTTT

UnitedHealth Backs FY20 Outlook; Q1 Results Miss Estimates - Quick Facts

While reporting financial results for the first quarter on Wednesday, diversified health care company UnitedHealth Group, Inc. (UNH) maintained its earnings outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/3ciAvU1
via IFTTT

AstraZeneca To Test Blood Cancer Drug Calquence For Covid-19 Patients

AstraZeneca plc is set to test in a global clinical trial the potential of its blood cancer drug Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm) related to coronavirus infection in severely ill patients. Calquence is a next-generation, highly selective Bruton's tyrosine kinase (BTK) inhibitor currently used to treat certain types of blood cancers.

from RTT - Biotech https://ift.tt/2xtsP2G
via IFTTT

Stock Alert: Aldeyra Therapeutics Inc. (ALDX)

Shares of Aldeyra Therapeutics Inc. (ALDX) are surging over 18% in pre-market today, after the company announced positive top-line Phase 1 clinical trial results for ADX-629, a first-in-class orally available reactive aldehyde species (RASP) inhibitor in development for the treatment of systemic immune-mediated diseases. Aldeyra also announced Phase 2 clinical development plans for ADX-629.

from RTT - Before the Bell https://ift.tt/2VqoFkc
via IFTTT

Stock Alert: NantKwest Shares Up 48% In Pre-Market

Shares of NantKwest Inc. (NK) are rising over 48% in pre-market today, after the company announced that NantKwest and ImmunityBio Inc. are in active discussions with the U.S. Food and Drug Administration (FDA) for vaccines and therapeutics to combat COVID-19.

from RTT - Before the Bell https://ift.tt/2K6ClLH
via IFTTT

Easing Coronavirus Worries May Lead To Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to move to the upside after ending the previous session mixed.

from RTT - Market Analysis https://ift.tt/2xjQGSv
via IFTTT

Stock Alert: MEI Pharma Shares Surge 77% In Pre-Market

Shares of MEI Pharma Inc. (MEIP) are soaring over 77% in pre-market today, the company entered into a global license, development and commercialization agreement with Kyowa Kirin Co. Ltd. to further develop and commercialize MEI's ME-401, an oral, once-daily, investigational drug-candidate, selective for phosphatidylinositol 3-kinase delta, in clinical development for the treatment of B-cell malignancies.

from RTT - Before the Bell https://ift.tt/3eviTqa
via IFTTT

Invacare Expects Q1 Net Sales To Decline 2.2% - Quick Facts

Medical equipment maker Invacare Corp. (IVC) announced Tuesday that it expects to report unaudited and preliminary net sales for first quarter of about $218.0 million, a decrease of roughly 2.2% compared to the prior year.

from RTT - Earnings https://ift.tt/2V6xHnd
via IFTTT

Stock Alert: Co-Diagnostics Inc. (CODX)

Shares of Co-Diagnostics Inc. (CODX) are rising over 4% in pre-market today, after the company announced that it has contracted with Promega Corp. for additional manufacturing capacity for immediate production of the company's Logix Smart COVID-19 test, as the company seeks to expand its domestic outreach to public and private laboratories in the United States.

from RTT - Before the Bell https://ift.tt/2RDF8QL
via IFTTT

J&J Q1 Results Top Estimates; Cuts 2020 Outlook Due To COVID-19 Impact

Johnson & Johnson (JNJ) reported that its profit for first-quarter 2020 rose 54.6 percent from last year, while quarterly sales increased 3.3 percent. Both adjusted earnings per share and revenues topped analysts' expectations. It boosted its dividend by 6.3%. It lowered its 2020 guidance to reflect the COVID-19 impact and related investments.

from RTT - Earnings https://ift.tt/2RBprcU
via IFTTT

JPMorgan Q1 Profit Plunge 69%, Results Miss Estimates - Quick Facts

JPMorgan Chase & Co. (JPM) reported Tuesday a profit for the first quarter that plunged 69 percent from last year, hurt by sharply higher provision for credit losses predominantly driven by reserve builds across the firm. Both earnings per share and revenue for the quarter missed analysts' expectations.

from RTT - Earnings https://ift.tt/2RERmsy
via IFTTT

AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550%

Today's Daily Dose brings you news about Amarin's preliminary Q1 revenue; Athersys' initiation of a phase II/III pivotal study of MultiStem therapy in COVID-19-induced acute respiratory distress syndrome; Fennec Pharma's regulatory catalyst in August; initial data of Gilead's Remdesivir in COVID-19 trial and SCWorx' receipt of a purchase order for two million COVID-19 Rapid Tests.

from RTT - Biotech https://ift.tt/3b8ynyf
via IFTTT

Athersys Approved To Start MultiStem Therapy Trial For COVID-19-Induced ARD

Athersys, Inc. said Monday it has received approval from the U.S. Food and Drug Administration to start a Phase 2/3 trial to assess the safety and efficacy of its MultiStem therapy in patients with moderate to severe acute respiratory distress syndrome or ARDS induced by COVID-19. According to the World Health Organization, ARDS is the leading cause of death among COVID-19 infected patients.

from RTT - Biotech https://ift.tt/3a7bWrE
via IFTTT

Stock Alert: Rite Aid Corp.(RAD)

Retail drugstore chain Rite Aid Corp. (RAD) is slated to report financial results for its Fiscal 2020 Fourth Quarter, which ended February 29, 2020, on Thursday, April 16, 2020.

from RTT - Earnings https://ift.tt/2V2Cjei
via IFTTT

Profit Taking May Lead To Initial Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Monday, with stocks likely to give back ground following the strong upward move seen last week.

from RTT - Market Analysis https://ift.tt/3em3bxA
via IFTTT

STERIS Receives FDA Emergency Use Authorization For Respirator Decontamination

STERIS plc (STE) said it received a FDA Emergency Use Authorization or EUA for respirator decontamination. The EUA allows healthcare providers to use some models of STERIS V-PRO Low Temperature Sterilization Systems to decontaminate N95 or N95-equivalent respirators on-site.

from RTT - Before the Bell https://ift.tt/34vCrG4
via IFTTT

Stock Alert: Alphabet Inc.

Shares of Alphabet Inc. (GOOG) are currently trading at $1,208.50, down $2.95 or 0.24% in the pre-market trading session. The stock has been trading in the range of $1,013.54 - $1,532.11 for the past one year, and closed Thursday's trade at $1,211.45, up $1.17 or 0.10%.

from RTT - Before the Bell https://ift.tt/2VrJZp8
via IFTTT

Seattle Genetics (SGEN) Merits Attention

Shares of Seattle Genetics Inc. (SGEN), which touched an all-time high of $128 on April 7, 2020, have since lost 6 percent of their value and trade around $120.

from RTT - Biotech https://ift.tt/3b7UOU7
via IFTTT

CytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection

CytoSorbents Corp. (CTSO) said Monday that the United States Food and Drug Administration has granted Emergency Use Authorization or EUA of CytoSorb for use in patients with COVID-19 infection.

from RTT - Biotech https://ift.tt/3cfmyXe
via IFTTT

Gilead Sciences Says Drug Shows Clinical Improvement In 68% Of Covid-19 Patients

Gilead Sciences, Inc. (GILD) says its experimental drug Remdesivir showed clinical improvement in 68% of Covid-19 patients, who were administered the drug on a compassionate-use basis. The details were published in The New England Journal of Medicine.

from RTT - Before the Bell https://ift.tt/2xtf2cr
via IFTTT

Belden Provides Preliminary Q1 Results; Withdraws FY20 Outlook - Quick Facts

Belden Inc. (BDC), a supplier of specialty networking solutions, today announced preliminary results for the fiscal first quarter of 2020. In addition, the company said it is withdrawing its outlook for full-year 2020 revenue and earnings per share that it previously provided, as the prior guidance did not reflect any impact from COVID-19.

from RTT - Earnings https://ift.tt/3b0TlyS
via IFTTT

Stock Alert: Microsoft Corp.

Shares of Microsoft Corp. (MSFT) are currently trading at $164.40, down $0.74 or 0.45% in the pre-market trading session. The stock has been trading between $119.01 and $190.70 in the past one year, and closed Thursday's trade at $165.14, up 1 cent or 0.01%.

from RTT - Before the Bell https://ift.tt/2Xuxxrp
via IFTTT

Stock Alert: Netflix Inc.

Netflix Inc. (NFLX) stock has been trading between $252.28 and $393.52 for the past one year, and closed Thursday's trade at $370.72, down 40 cents or 0.11%, with marketcap of 162.68 billion. Trading volume was 7.71 million versus an average volume of 8.01 million shares. NFLX is currently trading at $370.19, down 53 cents or 0.14% in the pre-market trading session.

from RTT - Before the Bell https://ift.tt/34vnpjT
via IFTTT

Can-Fite Gets Approval For COVID-19 Clinical Trial For Piclidenoson In Israel

Israeli biotechnology company Can-Fite BioPharma Ltd. (CANF) announced Monday that it has received approval from the Institutional Review Board (IRB) at Rabin Medical Center to initiate a pilot clinical study of its drug candidate Piclidenoson for the treatment of moderate-to-severe symptoms in coronavirus (COVID-19) infected patients.

from RTT - Biotech https://ift.tt/2VnheKy
via IFTTT

Kadmon's (KDMN) ROCKstar - Will The Study Turn Out To Be True To Its Name?

The Company we are profiling today is also developing a drug for cGVHD - Kadmon Holdings Inc. (KDMN), and the drug candidate in focus is KD025.

from RTT - Biotech https://ift.tt/2V53ULM
via IFTTT

Will FDA Approve First NASH Drug In 2020?

Drinking too much alcohol can lead to the accumulation of fat in the liver, which in turn can lead to irreversible damage to the organ over the long run. But people who don't drink or drink very little also can develop a liver disease, which goes by the name non-alcoholic fatty liver disease, or NAFLD, a condition caused by the buildup of extra fat in liver cells.

from RTT - Biotech https://ift.tt/34mnBSc
via IFTTT

Futures Fluctuate As Traders Digest Jobless Claims, Fed Action

The major U.S. index futures are currently pointing to a higher opening on Thursday but have seen considerable volatility over the course of the morning.

from RTT - Market Analysis https://ift.tt/2Rju7Eb
via IFTTT

Loblaw Withdraws FY20 Outlook Due To COVID-19 Impact - Quick Facts

Loblaw Companies Ltd. (L.TO) said Thursday that it is withdrawing its financial outlook for fiscal 2020 due to the uncertainty created by the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/34yJPkl
via IFTTT

BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19

Today's Daily Dose brings you news about Bristol Myers' regulatory catalyst; Liquidia's pulmonary arterial hypertension drug candidate; Moleculin Biotech joining the bandwagon of COVID-19 drug development; MediciNova initiating a clinical trial of MN-166 for acute respiratory distress syndrome (ARDS) caused by COVID-19 and FDA approval of Pfizer's BRAFTOVI for yet another indication.

from RTT - Biotech https://ift.tt/3c7NBUh
via IFTTT

Optimism About Flattening Coronavirus Curve May Generate Early Buying Interest

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to move back to the upside following the downturn seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2yLoJmT
via IFTTT

Stock Alert: Alpha Pro Tech Shares Soar 24% On Strong Demand For N-95 Face Masks

Shares of Alpha Pro Tech Ltd. (APT) are surging over 24% in pre-market today, after the company announced a significant growth in orders of its proprietary N-95 Particulate Respirator face mask and face shields.

from RTT - Before the Bell https://ift.tt/3aURRGv
via IFTTT

Stock Alert: Novavax Shares Up 13% In Early Trading

Shares of Novavax, Inc. (NVAX) are rising over 13% in pre-market today, after the company announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax' proprietary nanoparticle technology, and would initiate a first-in-human trial in mid-May.

from RTT - Before the Bell https://ift.tt/2xgno6W
via IFTTT

H&C Food Recalls Enoki Mushrooms For Listeria Concerns

Brooklyn, New York-based H&C Food Inc. is recalling select Enoki mushrooms citing the possible presence of Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement. The recall involves 7.05 oz or 200G pack of Enoki mushrooms imported from Green Co. located in Korea. The affected Enoki mushrooms were distributed to New York, Maryland and Virginia areas.

from RTT - Biotech https://ift.tt/2x4dBBb
via IFTTT

MSC Industrial Suspends Quarterly Financial Guidance Amid COVID-19 - Quick Facts

While reporting financial results for the second quarter on Wednesday, MSC Industrial Supply Co. (MSM) said it will not be providing its quarterly financial guidance until the period of heightened uncertainty passes amid the ongoing coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/3e3ftuo
via IFTTT

Zelira Therapeutics Says Medical Marijuana Drug Effective In Insomnia Trial

Australia-based medical cannabis company Zelira Therapeutics Ltd. said Tuesday that clinical trials showed the company's medical marijuana drug candidate successfully treated chronic insomnia.

from RTT - Biotech https://ift.tt/34iPivg
via IFTTT

KPTI To Test XPOVIO In COVID-19, PTCT Will Have To Wait, SAGE Slashes Workforce

Today's Daily Dose brings you news about Idera's private placement; Karyopharm's COVID-19 drug initiative; Merck's regulatory catalyst in June; delay in FDA decision of PTC Therapeutics' spinal muscular atrophy drug candidate and Sage Therapeutics' cost-cutting measures.

from RTT - Biotech https://ift.tt/2wo09HL
via IFTTT

The global stock market rally feels fragile | Nils Pratley

Shares have bounced back but it’s too soon to call the bottom for prices in the Covid-19 pandemic

Have we seen the bottom for stock markets? It is tempting to believe so after two days of fast action as investors have responded to the welcome sight of flatter coronavirus curves in Italy, Spain and Germany.

Some of the gains in individual stocks – those that had fallen the furthest – have been stunning. Speedy boarders could have made a 27% return in 48 hours by buying shares in easyJet first thing on Monday morning. In the same short period, Rolls-Royce, the engine-maker, gained 24%. Like easyJet, it was able to unveil a self-help strategy involving more borrowing.

Related: FTSE shrugs off dire UK data as markets sense easing of Covid-19 crisis

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/3aUL9jy

Stock Alert: Wingstop Up 9% As Sales Rise Despite COVID-19 Pandemic

Shares of Wingstop Inc. (WING) are gaining about 9% on Tuesday morning after the chicken wings restaurant reported a preliminary first-quarter results that recorded growth in sales.

from RTT - Earnings https://ift.tt/2RmOTmq
via IFTTT

Stock Alert: Kazia Therapeutics (KZIA)

Kazia Therapeutics Limited (KZIA), an Australian oncology-focused biotechnology company, has reported positive interim data from its ongoing phase II study of Paxalisib in glioblastoma, the most common and most aggressive form of primary brain cancer.

from RTT - Biotech https://ift.tt/39SlBSQ
via IFTTT

Futures Pointing To Another Early Rally On Wall Street

The major U.S. index futures are currently pointing to a sharply higher open on Tuesday, with stocks likely to extend the rally seen in the previous session.

from RTT - Market Analysis https://ift.tt/2yCeaSR
via IFTTT

Stock Alert: Pluristem Shares Up 33% In Pre-Market

Shares of Pluristem Therapeutics Inc. (PSTI) are surging over 33% in pre-market today, after the company announced preliminary data from its compassionate use program, treating seven patients suffering from acute respiratory failure and inflammatory complications associated with COVID-19 with Pluristem's PLX cells, in three medical centers in Israel.

from RTT - Before the Bell https://ift.tt/2USYlA9
via IFTTT

IMMU Soars, MLND Leaves Investors Starved, VIR, GSK To Develop COVID-19 Drugs

Today's Daily Dose brings you news about Co-Diagnostics securing FDA's Emergency Use Authorization for its SARS-CoV-2 diagnostic test; Immunomedics' ASCENT study; Millendo's disappointing Prader-Willi syndrome data; Menlo's failed Serlopitant trials; Mesoblast jumping into the COVID-19 drug development bandwagon and Vir Biotechnology's collaboration with GlaxoSmithKline.

from RTT - Biotech https://ift.tt/2RjyG1b
via IFTTT

Samsung Sees 2.7% Rise In Q1 Operating Profit

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its first-quarter operating profit will increase about 2.73 percent from last year, sales will also increase 4.98 percent.

from RTT - Earnings https://ift.tt/2wjPcah
via IFTTT

JPMorgan CEO Says Might Suspend Dividend In Extremely Adverse Scenario

JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario.

from RTT - Earnings https://ift.tt/2JHPaMz
via IFTTT

FDA Launches Effort To Develop Blood-related Therapies For COVID-19

The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered.

from RTT - Biotech https://ift.tt/3aPHovR
via IFTTT

Stock Alert: Wayfair Surges 42% On Upbeat Outlook

Shares of Wayfair Inc. (W) are surging more than 42 percent in Monday's trading at $71.97 after the online furniture retailer said it expects to meet or exceed its financial outlook for the first quarter of 2020. The stock has traded in a range of $21.70 to $166.40 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3aPJmfJ
via IFTTT

Stock Alert: Vir Biotechnology Shares Soar 26% In Pre-Market

Shares of Vir Biotechnology Inc. (VIR) are rising over 26% in pre-market today, after the company announced signing of a binding agreement to enter into a collaboration with GlaxoSmithKline plc (GSK) to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

from RTT - Before the Bell https://ift.tt/39LOAYw
via IFTTT

INOVIO Plans First Dose In Phase 1 Clinical Trial Of Its COVID-19 Vaccine Today

INOVIO Pharmaceuticals, Inc. (INO) announced Monday that it plans the first dose of its COVID-19 vaccine today as it initiates Phase 1 clinical efficacy trial of INO-4800, its DNA vaccine candidate, in healthy volunteers.

from RTT - Biotech https://ift.tt/2UN7B8K
via IFTTT

Signs Coronavirus Pandemic Easing May Lead To Rally On Wall Street

The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to move back to the upside following the weakness seen last Friday.

from RTT - Market Analysis https://ift.tt/2XfuNxV
via IFTTT

Stock Alert: RedHill Biopharma Shares Up 23% In Pre-Market

Shares of RedHill Biopharma Ltd. (RDHL) are rising over 23% in pre-market today, after the company announced that the first patient with confirmed coronavirus (COVID-19) diagnosis has been dosed with the company's proprietary investigational new drug, opaganib (Yeliva, ABC294640)1, at a leading hospital in Israel.

from RTT - Before the Bell https://ift.tt/2V7fftr
via IFTTT

Stock Alert: FDA Clears Mesoblast's IND For Remestemcel-L; Stock Up 36%

Shares of Mesoblast Ltd. (MESO) are surging over 36% in pre-market today, after the company announced that the U.S. FDA has cleared its Investigational New Drug or IND application to use intravenous infusions of its allogeneic mesenchymal stem cell or MSC product candidate remestemcel-L to treat patients with acute respiratory distress syndrome or ARDS caused by coronavirus infection (COVID-19).

from RTT - Before the Bell https://ift.tt/2JKJi4W
via IFTTT

Co-Diagnostics Gets EUA From FDA For Logix Smart COVID-19 Test - Quick Facts

Molecular diagnostics company Co-Diagnostics, Inc. (CODX) announced Monday that its Logix Smart coronavirus COVID-19 test has obtained Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to be used for the diagnosis of SARS-CoV-2.

from RTT - Biotech https://ift.tt/2Vasw4u
via IFTTT

CytoDyn Enrolls First Two Patients In Phase 2 COVID-19 Trial With Leronlimab

Biotechnology company CytoDyn Inc. (CYDY.OB) announced Monday that it has enrolled and treated the first two COVID-19 patients with leronlimab under its Phase 2 randomized clinical trial, which is for patients with mild-to-moderate indications. The Company anticipates that enrollment of more patients will accelerate this week at multiple clinical sites.

from RTT - Biotech https://ift.tt/2V6T7j6
via IFTTT

Acreage Holdings Temporarily Furloughs 122 Workers; Terminates Acquisition

New York-based cannabis company Acreage Holdings Inc. has temporarily furloughed 122 employees, terminated its acquisition of Nevada-based Deep Roots Medical LLC, and announced other cost-cutting measures in response to the coronavirus pandemic.

from RTT - Earnings https://ift.tt/2UKfVWF
via IFTTT

Anti-parasitic Drug Killed COVID-19 Virus In Cell Culture In 2 Days: Study

A study conducted by scientists from Australia's Monash Biomedicine Discovery Institute and the Doherty Institute has found that an FDA-approved medicine Ivermectin that is currently used to treat parasite infections such as intestinal worms, lice, and mites, can kill the virus within 48 hours in cell culture.

from RTT - Biotech https://ift.tt/3bVgLG1
via IFTTT

Decoding COVID-19 - Some Known Questions, Some Unknown Answers

Currently, there are no treatments or vaccines for COVID-19. A number of companies are racing to find a treatment or vaccine for the same. What is the latest by which a vaccine for COVID-19 will be available?

from RTT - Biotech https://ift.tt/2V1Jh1H
via IFTTT

Stock Alert: I-Mab Shares Up 6% In Pre-Market

Shares of I-Mab (IMAB) are rising over 6% in pre-market today, after the company announced that the U.S. FDA has cleared the company's Investigational New Drug application or IND to initiate clinical study for TJM2 to treat cytokine release syndrome or CRS associated with severe illness caused by the coronavirus disease 2019 (COVID-19).

from RTT - Before the Bell https://ift.tt/2R9v69L
via IFTTT

Disappointing Jobs Data May Weigh On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Friday, with stocks likely to give back ground after ending the previous session significantly higher.

from RTT - Market Analysis https://ift.tt/3bM2I5y
via IFTTT

Stock Alert: Capricor Therapeutics Stock Up 26% In Pre-Market

Shares of Capricor Therapeutics Inc. (CAPR) are soaring over 26% in pre-market today, after the company announced it is providing CAP-1002, its novel cell therapy to patients with advanced COVID-19 under the compassionate use pathway.

from RTT - Before the Bell https://ift.tt/2JCHjzK
via IFTTT

Stock Alert: Fate Therapeutics Stock Up 21% In Pre-Market

Shares of Fate Therapeutics Inc. (FATE) are rising over 21% in pre-market today. The stock has been trading in the range of $12.59 - $32.39 for the past one year, and closed Thursday's trade at $21.07, up 86 cents or 4.26%. FATE is currently trading at $25.50, up $4.43 or 21.03% in the pre-market trading session.

from RTT - Before the Bell https://ift.tt/3dLzPZ7
via IFTTT

Stock Alert: Tesla Shares Up 16% In Pre-Market

Shares of Tesla Inc. (TSLA) are rising over 16% in pre-market today, following the company's strong Q1 vehicle production and deliveries report.

from RTT - Before the Bell https://ift.tt/2R8iYWN
via IFTTT

Xinyuan Provides FY20 Outlook - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2019 on Friday, Chinese real estate developer Xinyuan Real Estate Co., Ltd. (XIN) said it expects contract sales for the full year 2020 to be in the range of RMB 20 billion and RMB 22 billion.

from RTT - Earnings https://ift.tt/2wYD4vD
via IFTTT

Fate Therapeutics Seals Deal With JNJ For Cancer Immunotherapies, Stock Jumps

Shares of Fate Therapeutics Inc. (FATE) were up over 20 percent in extended trading on Thursday, following a worldwide collaboration with Johnson & Johnson subsidiary (JNJ) Janssen for novel induced pluripotent stem cell-derived cell-based cancer immunotherapies.

from RTT - Biotech https://ift.tt/3aF57ij
via IFTTT

Boston Scientific To Significantly Cut Salaries Of CEO, Directors

Boston Scientific Corp. said Thursday that to lessen the impact of the coronavirus pandemic on its business, it will significantly reduce the salaries of its chief executive officer, directors and executive committee members. The company also intends to temporarily reduce work week schedules for employees, where appropriate. The medical device maker said these measures are to reduce costs.

from RTT - Earnings https://ift.tt/2R5s2M6
via IFTTT

What's The Buzz About Amarin Corp. (AMRN)?

Shares of Amarin Corporation plc (AMRN), which touched a 52-week low of $3.95 on March 31, 2020, following an unfavorable ruling in a patent case related to Vascepa, have since gained 38% as of this writing.

from RTT - Biotech https://ift.tt/3dRhnhx
via IFTTT